Completed

A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome

F1J-MC-HMGW - ClinicalTrials.gov - NCT01237587

The purpose of this study is to determine whether duloxetine is safe and effective in the treatment of adolescents with Juvenile Primary Fibromyalgia Syndrome (JPFS). This trial consists of two distinct study periods; a blinded treatment period of 13 weeks and an open label extension period of 26 weeks.
How long will I be in the trial?
Your participation could last up to 39 weeks and include 15 visits to the study center
Email
Completed

A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome

F1J-MC-HMGW - ClinicalTrials.gov - NCT01237587

The purpose of this study is to determine whether duloxetine is safe and effective in the treatment of adolescents with Juvenile Primary Fibromyalgia Syndrome (JPFS). This trial consists of two distinct study periods; a blinded treatment period of 13 weeks and an open label extension period of 26 weeks.
How long will I be in the trial?
Your participation could last up to 39 weeks and include 15 visits to the study center
Email

Key Requirements

Age :

13-17

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

13-17

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Fibromyalgia

What the trial is testing?

interventions example

Could I receive a Placebo?

yes

Enrollment Goal

210

Trial Dates

March 2011 - November 2017

Trial Phase

3

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

13-17

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Fibromyalgia

What the trial is testing?

interventions example

Could I receive a Placebo?

yes

Enrollment Goal

210

Trial Dates

March 2011 - November 2017

Trial Phase

3

Not the right fit? Sign up to receive updates on new Fibromyalgia trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

By clicking the checkbox and using the map, you agree to allow Google Maps to collect your personal information in accordance with their Privacy Policy

Fibromyalgia Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?